Tissue Injury and the Skin

Systemic Lupus Erythematosus

Volumn , Issue , 2011, Pages 475-489

  Kuhn, Annegret ^a   Böhm, Markus ^a   Luger, Thomas A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884785291     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374994-9.10027-0     Document Type: Chapter

References (164)

1. Cohen A.S., Reynolds W.E., Franklin E.C., Kulka J.P., Ropes M.W., Shulman L.E., et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971, 21:643-648.
2. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
3. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
4. Albrecht J., Berlin J.A., Braverman I.M., Callen J.P., Connolly M.K., Costner M.I., et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 2004, 13:839-849.
5. Kuhn A., Aberer E., C., B., Foeldvari I., Haust M., Iking-Konert C., Kind P., et al. Leitlinien Kutaner Lupus Erythematodes (Entwicklungsstufe 1). Dermatologische Qualitätssicherung: Leitlinien und Empfehlungen 2009, 214-257. ABW Wissenschaftsverlag GmbH, Berlin. H.C. Korting, R. Callies, M. Reusch, M. Schlaeger, W. Sterry (Eds.).
6. Sontheimer R.D. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 2005, 4:253-263.
7. Werth V.P., Zhang W., Dortzbach K., Sullivan K. Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000, 115:726-730.
8. Kuhn A., Herrmann M., Kleber S., Beckmann-Welle M., Fehsel K., Martin-Villalba A., et al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 2006, 54:939-950.
9. Franz B., Fritzsching B., Riehl A., Oberle N., Klemke C.D., Sykora J., et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 2007, 56:1910-1920.
10. Wenzel J., Zahn S., Bieber T., Tuting T. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus. Arch Dermatol Res 2009, 301:83-86.
11. Gilliam J.N. The cutaneous signs of lupus erythematosus. Cont Educ Fam Phys. 1977, 6:34-70.
12. Costner M.I., Sontheimer R.D., Provost T.T. Lupus erythematosus. Cutaneous Manifestations of Rheumatic Diseases 2003, 15-64. Williams & Wilkins, Philadelphia. R.D. Sontheimer, T.T. Provost (Eds.).
13. Schmitt V., Meuth A.M., Amler S., Kuehn E., Haust M., Messer G., et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Br J Dermatol 2010, 162:64-73.
14. Kuhn A., Bein D., Bonsmann G. The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev. 2009, 8:441-448.
15. Kuhn A., Ruzicka T. Classification of cutaneous lupus erythematosus. Cutaneous Lupus Erythematosus 2004, 53-58. Springer, Heidelberg. A. Kuhn, P. Lehmann, T. Ruzicka (Eds.).
16. Ackermann A.B. Lupus erythematosus. Histologic Diagnosis of Inflammatory Skin Diseases 1997, 525-546. Williams & Wilkins, Baltimore.
17. Jerdan M.S., Hood A.F., Moore G.W., Callen J.P. Histopathologic comparison of the subsets of lupus erythematosus. Arch Dermatol 1990, 126:52-55.
18. Ardigo M., Maliszewski I., Cota C., Scope A., Sacerdoti G., Gonzalez S., et al. Preliminary evaluation of in vivo reflectance confocal microscopy features of Discoid lupus erythematosus. Br J Dermatol 2007, 156:1196-1203.
19. Bangert J.L., Freemann R.G., Sontheimer R.D., Gilliam J.N. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol 1984, 120:332-337.
20. Sontheimer R.D., Thomas J.R., Gilliam J.N. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979, 115:1409-1415.
21. Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol 2004, 22:129-138.
22. Doutre M.S., Beylot C., Beylot J., Pompougnac E., Royer P. Chilblain lupus erythematosus: report of 15 cases. Dermatology 1992, 184:26-28.
23. Pock L., Petrovska P., Becvar R., Mandys V., Hercogova J. Verrucous form of chilblain lupus erythematosus. J Eur Acad Dermatol Venereol 2001, 15:448-451.
24. Massone C., Kodama K., Salmhofer W., Abe R., Shimizu H., Parodi A., et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol 2005, 32:396-404.
25. Sanchez N.P., Peters M.S., Winkelmann R.K. The histopathology of lupus eyrthematosus panniculitis. J Am Acad Dermatol 1981, 122:576-582.
26. Alexiades-Armenakas M.R., Baldassano M., Bince B., Werth V., Bystryn J.C., Kamino H., et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum 2003, 15:494-500.
27. Kuhn A., Sonntag M., Ruzicka T., Lehmann P., Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol 2003, 48:901-908.
28. Hexsel C.L., Bangert S.D., Hebert A.A., Lim H.W. Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products. J Am Acad Dermatol 2008, 59:316-323.
29. Gonzalez E.G., Selvi E., Lorenzini S., Maggio R., Mannucci S., Galeazzi M., et al. Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clin Rheumatol 2007, 26:244-246.
30. Cardinali C., Caproni M., Fabbri P. The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus. Clin Exp Rheumatol 1999, 17:427-432.
31. Cardinali C., Caproni M., Fabbri P. The composition of the lupus band test (LBT) on the sun-protected non-lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE). Lupus 1999, 8:755-760.
32. Prystowsky S.D., Herndon J.H., Gilliam J.N. Chronic cutaneous lupus erythematosus (DLE): a clinical and laboratory investigation of 80 patients. Medicine 1975, 55:183.
33. Vieira V., Del Pozo J., Yebra-Pimentel M.T., Martinez W., Fonseca E. Lupus erythematosus tumidus: a series of 26 cases. Int J Dermatol 2006, 45:512-517.
34. Choonhakarn C., Poonsriaram A., Chaivoramukul J. Lupus erythematosus tumidus. Int J Dermatol 2004, 43:815-818.
35. Gammon W.R., Briggaman R.A. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 1993, 100:28S-34S.
36. Nitta Y., Kawamura C., Hashimoto T. Vesiculobullous systemic lupus erythematosus: a case with circulating IgG and IgA autoantibodies to type VII collagen. J Am Acad Dermatol 2002, 47:S283-286.
37. Yang S., Gao Y., Song Y., Liu J., Yang C., Wang Z., et al. The study of the participation of basement membrane zone antibodies in the formation of the lupus band in systemic lupus erythematosus. Int J Dermatol 2004, 43:420-427.
38. Halberg P., Ullman S., Jorgensen F. The lupus band test as a measure of disease activity in systemic lupus erythematosus. Arch Dermatol 1982, 118:572-576.
39. Sontheimer R.D., Gilliam J.N. A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol 1979, 72:29-32.
40. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
41. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
42. Zhou L., Ivanov, Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007, 8:967-974.
43. Stritesky G.L., Yeh N., Kaplan M.H. IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol 2008, 181:5948-5955.
44. Hasan T., Stephansson E., Ranki A. Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption. Acta Derm Venereol 1999, 79:437-442.
45. Prinz J.C., Meurer M., Reiter C., Rieber E.P., Plewig G., Riethmuller G. Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 1996, 34:244-252.
46. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 2009, 265:644-652.
47. Nalbandian A., Crispin J.C., Tsokos G.C. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009, 157:209-215.
48. Wong C.K., Ho C.Y., Li E.K., Lam C.W. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000, 9:589-593.
49. Wong C.K., Lit L.C., Tam L.S., Li E.K., Wong P.T., Lam C.W. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008, 127:385-393.
50. Crispin J.C., Oukka M., Bayliss G., Cohen R.A., Van Beek C.A., Stillman I.E., et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008, 181:8761-8766.
51. Zhang Z., Kyttaris V.C., Tsokos G.C. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 2009, 183:3160-3169.
52. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
53. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
54. Crispin J.C., Martinez A., Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003, 21:273-276.
55. Mellor-Pita S., Citores M.J., Castejon R., Tutor-Ureta P., Yebra-Bango M., Andreu J.L., et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 2006, 65:553-554.
56. Lyssuk E.Y., Torgashina A.V., Soloviev S.K., Nassonov E.L., Bykovskaia S.N. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007, 601:113-119.
57. Valencia X., Yarboro C., Illei G., Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
58. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
59. Lee J.H., Wang L.C., Lin Y.T., Yang Y.H., Lin D.T., Chiang B.L. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006, 117:280-286.
60. Wu H.Y., Staines N.A. A deficiency of CD4+CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 2004, 13:192-200.
61. Kuhn A., Beissert S., Krammer P.H. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res. 2009, 301:71-81.
62. Monk C.R., Spachidou M., Rovis F., Leung E., Botto M., Lechler R.I., et al. MRL/Mp CD4+, CD25- T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 2005, 52:1180-1184.
63. Venigalla R.K., Tretter T., Krienke S., Max R., Eckstein V., Blank N., et al. Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008, 58:2120-2130.
64. Janssens A.S., Lashley E.E., Out-Luiting C.J., Willemze R., Pavel S., de Gruijl F.R. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells. Exp Dermatol 2005, 14:138-142.
65. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175-179.
66. Josien R., Wong B.R., Li H.L., Steinman R.M., Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999, 162:2562-2568.
67. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997, 186:2075-2080.
68. Cremer I., Dieu-Nosjean M.C., Marechal S., Dezutter-Dambuyant C., Goddard S., Adams D., et al. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 2002, 100:3646-3655.
69. Loser K., Mehling A., Loeser S., Apelt J., Kuhn A., Grabbe S., et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006, 12:1372-1379.
70. Toberer F., Sykora J., Göttel D., Schmitt V., Loser K., Beissert S., et al. Differential expression of RANKL in infammatory skin diseases. J Invest Derm 2009, 129. Abstract ESDR.
71. Andrews B.S., Schenk A., Barr R., Friou G., Mirick G., Ross P. Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies. J Am Acad Dermatol 1986, 15:474-481.
72. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001, 159:237-243.
73. Wollenberg A., Wagner M., Gunther S., Towarowski A., Tuma E., Moderer M., et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002, 119:1096-1102.
74. Wenzel J., Worenkamper E., Freutel S., Henze S., Haller O., Bieber T., et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005, 205:435-442.
75. Nyberg F., Hasan T., Skoglund C., Stephansson E. Early events in ultraviolet light-induced skin lesions in lupus erythematosus: expression patterns of adhesion molecules ICAM-1, VCAM-1 and E-selectin. Acta Derm Venereol 1999, 79:431-436.
76. Stephansson E., Ros A.M. Expression of intercellular adhesion molecule-1 (ICAM-1) and OKM5 in UVA- and UVB-induced lesions in patients with lupus erythematosus and polymorphous light eruption. Arch Dermatol Res 1993, 285:328-333.
77. Jones S.M., Mathew C.M., Dixey J., Lovell C.R., McHugh N.J. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma. Br J Dermatol 1996, 135:678-686.
78. Belmont H.M., Buyon J., Giorno R., Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994, 37:376-383.
79. Kuhn A., Sonntag M., Lehmann P., Megahed M., Vestweber D., Ruzicka T. Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus. Arch Dermatol Res 2002, 294:6-13.
80. Nyberg F., Acevedo F., Stephansson E. Different patterns of soluble adhesion molecules in systemic and cutaneous lupus erythematosus. Exp Dermatol 1997, 6:230-235.
81. Brey R.L., Sakic B., Szechtman H., Denburg J.A. Animal models for nervous system disease in systemic lupus erythematosus. Ann N Y Acad Sci 1997, 823:97-106.
82. Kuhn A., Beissert S. Photosensitivity in lupus erythematosus. Autoimmunity 2005, 38:519-529.
83. Pusey W.A. Attacks of lupus erythematosus following exposure to sunlight or other weather factors. Arch Dermatol Syph 1915, 33:388.
84. Sutej P.G., Gear A.J., Morrison R.C., Tikly M., de Beer M., Dos Santos L., et al. Photosensitivity and anti-Ro (SS-A) antibodies in black patients with systemic lupus erythematosus (SLE). Br J Dermatol 1989, 28:321-324.
85. Walchner M., Messer G., Kind P. Phototesting and photoprotection in LE. Lupus 1997, 6:167-174.
86. Cripps D.J., Rankin J. Action spectra of lupus erythematosus and experimental immunofluorescence. Arch Dermatol 1973, 107:563-567.
87. Freeman R.G., Knox J.M., Owens D.W. Cutaneous lesions of lupus erythematosus induced by monochromatic light. Arch Dermatol 1969, 100:677-682.
88. Lehmann P., Hölzle E., von Kries R., Plewig G. Lichtdiagnostische Verfahren bei Patienten mit Verdacht auf Photodermatosen. Zentralblatt Haut- und Geschlechtskrankheiten 1986, 152:667-682.
89. Lehmann P., Hölzle E., Kind P., Goerz G., Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990, 22:181-187.
90. Stern R.S., Docken W. An exarcerbation of SLE after vistiting a tanning salon. JAMA 1986, 255:3120.
91. Tronnier H., Petri H., Pierchalla P. UV-provozierte bullöse Hautveränderungen bei systemischem Lupus erytematodes. Z Hautkr 1988, 154:616-617.
92. Kuhn A., Sonntag M., Richter-Hintz D., Oslislo C., Megahed M., Ruzicka T., et al. Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 2001, 45:86-95.
93. Kuhn A., Sonntag M., Richter-Hintz D., Oslislo C., Megahed M., Ruzicka T., et al. Phototesting in lupus erythematosus tumidus-review of 60 patients. Photochem Photobiol 2001, 73:532-536.
94. Kuhn A., Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus 2008, 17:389-393.
95. Weedon D., Strutton G. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol 1981, 61:335-339.
96. Budtz P.E., Spies I. Epidermal homeostasis - apoptosis and cell emigration as mechanisms of controlled cell deletion in the epidermis of the toad, Bufo bufo. Cell Tissue Res 1989, 256:475-486.
97. McCall C.A., Cohen J.J. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 1991, 97:111-114.
98. Norris D.A., Whang K., David-Bajar K., Bennion S.D. The influence of ultraviolet light on immunological cytotoxicity in the skin. Photochem Photobiol 1997, 65:636-646.
99. Daniels F., Brophy D., Lobitz W.C. Histochemical responses of human skin following ultraviolet irradiation. J Invest Dermatol 1961, 37:351-357.
100. Baima B., Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001, 144:958-966.
101. Chung J.H., Kwon O.S., Eun H.C., Youn J.I., Song Y.W., Kim J.G., et al. Apoptosis in the pathogenesis of cutaneous lupus erythematosus. Am J Dermatopathol 1998, 20:233-241.
102. Pablos J.L., Santiago B., Galindo M., Carreira P.E., Ballestin C., Gomez-Reino J.J. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol 1999, 188:63-68.
103. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241-1250.
104. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:191-201.
105. Gaipl U.S., Kuhn A., Sheriff A., Munoz L.E., Franz S., Voll R.E., et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 2006, 9:173-187.
106. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., et al. Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 2004, 34:921-929.
107. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997, 158:4525-4528.
108. Nepomuceno R.R., Henschen-Edman A.H., Burgess W.H., Tenner A.J. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 1997, 6:119-129.
109. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998, 19:56-59.
110. Bowness P., Davies K.A., Norsworthy P.J., Athanassiou P., Taylor-Wiedeman J., Borysiewicz L.K., et al. Hereditary C1q deficiency and systemic lupus erythematosus. Qjm 1994, 87:455-464.
111. Pickering M.C., Fischer S., Lewis M.R., Walport M.J., Botto M., Cook H.T. Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice. J Invest Dermatol 2001, 117:52-58.
112. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
113. Casciola-Rosen L.A., Anhalt G.J., Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995, 182:1625-1634.
114. Utz P.J., Hottelet M., Schur P.H., Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843-854.
115. Utz P.J., Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998, 41:1152-1160.
116. Greidinger E.L., Casciola-Rosen L., Morris S.M., Hoffman R.W., Rosen A. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 2000, 43:881-888.
117. Meller S., Winterberg F., Gilliet M., Muller A., Lauceviciute I., Rieker J., et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005, 52:1504-1516.
118. Wenzel J., Henze S., Worenkamper E. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL 17 for lymphocyte recruitment in cutaneous lupus erythematosus. J Invest Dermatol 2005, 124:1241-1248.
119. Baechler E.C., Gregersen P.K., Behrens T.W. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 2004, 16:801-807.
120. Cals-Grierson M.M., Ormerod A.D. Nitric oxide function in the skin. Nitric Oxide 2004, 10:179-193.
121. Suschek C.V., Krischel V., Bruch-Gerharz D., Berendji D., Krutmann J., Kroncke K.D., et al. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. J Biol Chem 1999, 274:6130-6137.
122. Weller R., Schwentker A., Billiar T.R., Vodovotz Y. Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis. Am J Physiol Cell Physiol 2003, 284:C1140-1148.
123. Ormerod A.D., Copeland P., Hay I., Husain A., Ewen S.W. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. J Invest Dermatol 1999, 113:392-397.
124. Kuhn A., Fehsel K., Lehmann P., Krutmann J., Ruzicka T., Kolb-Bachofen V. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 1998, 111:149-153.
125. Belmont H.M., Levartovsky D., Goel A., Amin A., Giorno R., Rediske J., et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:1810-1816.
126. Lopez-Nevot M.A., Ramal L., Jimenez-Alonso J., Martin J. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 2003, 42:113-116.
127. Lawrence J.S., Martins C.L., Drake G.L. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987, 14:913-921.
128. Yeaman G.R., Froebel K., Galea G., Ormerod A., Urbaniak S.J. Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease. Br J Dermatol 1992, 126:60-65.
129. Wolpert K.A., Webster A.D., Whittaker S.J. Discoid lupus erythematosus associated with a primary immunodeficiency syndrome showing features of non-X-linked hyper-IgM syndrome. Br J Dermatol 1998, 138:1053-1057.
130. Millard T.P., Kondeatis E., Vaughan R.W., Lewis C.M., Khamashta M.A., Hughes G.R., et al. Polymorphic light eruption and the HLA DRB10301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 2001, 10:473-479.
131. Millard T.P., Lewis C.M., Khamashta M.A., Hughes G.R., Hawk J.L., McGregor J.M. Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathogenesis. Br J Dermatol 2001, 144:334-338.
132. Price P., Witt C., Allcock R., Sayer D., Garlepp M., Kok C.C., et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999, 167:257-274.
133. Harley J.B., Reichlin M., Arnett F.C., Alexander E.L., Bias W.B., Provost T.T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 1986, 232:1145-1147.
134. Braathen L.R., Bratlie A., Teisberg P. HLA genotypes in a family with a case of homozygous C2 deficiency and discoid lupus erythematosus. Acta Derm Venereol 1986, 66:419-422.
135. Provost T.T., Arnett F.C., Reichlin M. Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum 1983, 26:1279-1282.
136. Callen J.P., Hodge S.J., Kulick K.B., Stelzer G., Buchino J.J. Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency. Arch Dermatol 1987, 123:66-70.
137. Levy S.B., Pinnell S.R., Meadows L., Snyderman R., Ward F.E. Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory, and genetic studies. Arch Dermatol 1979, 115:57-61.
138. Meyer O., Hauptmann G., Tappeiner G., Ochs H.D., Mascart-Lemone F. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol 1985, 62:678-684.
139. Nousari H.C., Kimyai-Asadi A., Provost T.T. Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4. J Am Acad Dermatol 1999, 41:362-364.
140. Shapiro M., Sosis A.C., Junkins-Hopkins J.M., Werth V.P. Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual. Int J Dermatol 2004, 43:87-94.
141. Norris D.A. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993, 100:58S-68S.
142. Rood M.J., van Krugten M.V., Zanelli E., van der Linden M.W., Keijsers V., Schreuder G.M., et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000, 43:129-134.
143. Pablos J.L., Carreira P.E., Martin-Villa J.M., Montalvo G., Arnaiz-Villena A., Gomez-Reino J.J. Polymorphism of the heat-shock protein gene HSP70-2 in systemic lupus erythematosus. Br J Rheumatol 1995, 34:721-723.
144. Ghoreishi M., Katayama I., Yokozeki H., Nishioka K. Analysis of 70 KD heat shock protein (HSP70) expression in the lesional skin of lupus erythematosus (LE) and LE related diseases. J Dermatol 1993, 20:400-405.
145. Villalobos-Hurtado R., Sanchez-Rogriguez S.H., Avalos-Diaz E., Herrera-Esparza R. Possible role of Hsp70 in autoantigen shuttling to the dermo-epidermal junction in systemic lupus erythematosus. Reumatismo 2003, 55:155-158.
146. Suzuki H., Matsui Y., Kashiwagi H. Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:389-390.
147. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
148. Lazarus M., Hajeer A.H., Turner D., Sinnott P., Worthington J., Ollier W.E., et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997, 24:2314-2317.
149. Frank M.B., McArthur R., Harley J.B., Fujisaku A. Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 1990, 85:33-39.
150. Ollier W., Davies E., Snowden N., Alldersea J., Fryer A., Jones P., et al. Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La- autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum 1996, 39:1763-1764.
151. Huang Q.R., Danis V., Lassere M., Edmonds J., Manolios N. Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology (Oxford) 1999, 38:645-651.
152. Furukawa F., Kanauchi H., Wakita H., Tokura Y., Tachibana T., Horiguchi Y., et al. Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice. J Invest Dermatol 1996, 107:95-100.
153. Johansson M., Arlestig L., Moller B., Smedby T., Rantapaa-Dahlqvist S. Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1611-1617.
154. Lee-Kirsch M.A., Gong M., Schulz H., Ruschendorf F., Stein A., Pfeiffer C., et al. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet 2006, 79:731-737.
155. Mazur D.J., Perrino F.W. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'>5' exonucleases. J Biol Chem 1999, 274:19655-19660.
156. Rice G., Newman W.G., Dean J., Patrick T., Parmar R., Flintoff K., et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 2007, 80:811-815.
157. Lee-Kirsch M.A., Chowdhury D., Harvey S., Gong M., Senenko L., Engel K., et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med 2007, 85:531-537.
158. Chowdhury D., Beresford P.J., Zhu P., Zhang D., Sung J.S., Demple B., et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006, 23:133-142.
159. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., Ali M., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006, 38:917-920.
160. Crow Y.J., Leitch A., Hayward B.E., Garner A., Parmar R., Griffith E., et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 2006, 38:910-916.
161. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.A., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39:1065-1067.
162. Yang Y.G., Lindahl T., Barnes D.E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 2007, 131:873-886.
163. Hubner N., Wallace C.A., Zimdahl H., Petretto E., Schulz H., Maciver F., et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 2005, 37:243-253.
164. Kuhn A., Gensch K., Stander S., Bonsmann G. Cutaneous lupus erythematosus: Part 2: Diagnostics and therapy. Hautarzt 2006, 57:345-360.